
Our iRT concept enables the efficient and accurate scheduling of MRM experiments. In combination with the iRT kit each peptide can be assigned a stable iRT value that allows for highly accurate prediction of retention time across...> More
Biognosys presents at the Personalized Medicine World Conference 2012 to win Most Promising Company Award.> More
The Swiss Commission for Technology and Innovation (CTI) has granted CHF 1.5m for a research collaboration between Biognosys and the group of Prof. Aebersold, ETH Zurich, to bring the novel HRM-MS technology to the market.> More
Setting up scheduled multiplexed MRM experiments and processing MRM signals is a challenge in proteomics research. Biognosys’ proprietary software mQuest / mProphet, the iRT-Kit and MRMbase assays resolve these issues (Reiter L,...> More
Biognosys attracted venture capital from experienced investors including Syngenta Ventures. > More
Biognosys ranked #12 of TOP100 Swiss Start-Ups and #3 among Life Science companies.> More
Biognosys is invited to present its iRT concept for mass spectrometry specialists.> More
On September 9th, 2011, Biognosys turns 3 years old...> More
Biognosys AG is participating in the 10th Annual World Congress of the Human Proteome Organisation in Geneva> More
Siena, Italy: Biognosys AG is entering into a collaboration with Novartis Vaccines and Diagnostics. > More
Biognosys is lecturing and exhibiting at the American Society for Mass Spectrometry Conference 2011 in Denver, Colorado (swing by Booth 28 if you’re attending). > More
Multiplex your MRM and save time. We’re discounting them during our launch> More
Need a new RT-Kit?
See our offers here.